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Antibiotic therapy predisposes the host to infectionswith human enteropathogens. In a recent study, Ng et al.
(2013) demonstrate that antibiotic-mediated disruption of the microbial food web gives rise to free
microbiota-liberated monosaccharides in the gut, which can promote growth of enteropathogenic bacteria.The discovery of antibiotics was a major
scientific breakthrough of the 20th cen-
tury. These ‘‘silver bullets’’ lead to a signif-
icant improvement in life expectancy
by enabling the cure of major human in-
fectious diseases. Antibiotics also come
with several downsides and therefore
need to be handled with care. On the
one hand, the emergence of multiple anti-
biotic-resistant pathogens relegates us to
the preantibiotic era for some diseases.
On the other hand, antibiotic application
causes collateral damage to our benefi-
cial commensal bacterial communities
(microbiota) and thereby negatively im-
pacts human health (Blaser, 2011). There
is ample evidence that antibiotic therapy
can dramatically increase the susceptibil-
ity to enteric and nosocomial infections
(e.g., Clostridium difficile). A connection
between antibiotics and an increased
susceptibility to colonization by contam-
inating organisms was already noted
in the early 1950s in the first patients
undergoing antibiotic therapy, which was
subsequently experimentally confirmed
(Bohnhoff et al., 1954). The underlying
reasons were attributed to the distur-
bance of the ‘‘normal flora’s’’ ecology,
which normally assists the host in defense
against pathogens.
This protective effect mediated by the
microbiota is termed colonization resis-
tance, but the underlying mechanistic
basis for this phenomenon is still poorly
understood. It is controversially dis-
cussed whether direct (microbe-path-
ogen) or indirect (host-pathogen) mech-
anisms play the key role. Let us first
consider direct microbiota-mediated
effects. The microbiota is a tightly struc-
tured ecosystem inwhich individual mem-bers effectively cooperate to degrade and
consume all available dietary and host-
derived nutrients. A subset of primary de-
graders solubilizes carbohydrates from
dietary fibers, resistant starches, and cel-
lulose as well as from host-derived poly-
meric glycoprotein (e.g., mucin). Thereby,
these bacteria make carbohydrates avail-
able to other cross-feeding bacteria in
the form of polysaccharides, oligosac-
charides, and simple sugars. The majority
of the primary and secondary degraders
are strictly anaerobic, fermentative bacte-
ria belonging to the Bacteroidetes and
Firmicutes phyla (Flint et al., 2008). The
end products of all complex fermentation
reactions in the gut are short-chain fatty
acids, H2, CO2, and CH4. Effective
nutrient depletion by this tightly organized
food web basically prevents growth of
new invaders that are unable to success-
fully compete with the local community for
nutrient niches.
Pathogens entering the gastrointestinal
tract have to consume energy-rich sub-
strates to replicate and reach sufficient
numbers in order to elicit disease. If local
colonizers occupy all nutrient niches that
could potentially be exploited by the path-
ogen, infection should be prevented (the
nutrient-niche hypothesis). This theory
was recently substantiated in the case of
human pathogenic enterohemorrhagic
E. coli (EHEC) infections (Maltby et al.,
2013). Streptomycin-treated mice are
highly susceptible to colonization by the
human pathogenic EHEC strain EDL933.
Recolonization of streptomycin-treated
mice with two commensal E. coli strains,
which concertedly consume all sugars
preferred by EDL933, fully established
colonization resistance. Each strain aloneCell Host & Microbe 14, Seor strains with a different sugar spectrum
did not prevent colonization. Similarly, in
a mouse model for antibiotic-triggered
C. difficile infection, a consortium of
six phylogenetically diverse commensal
strains was found to clear C. difficile
from the mice. Single strains or subdivi-
sions of this bacterial mixture failed, sug-
gesting that microbial diversity is a crucial
prerequisite for colonization resistance
(Lawley et al., 2012).
After antibiotic treatment, colonization
resistance is transiently reduced, and
the host is highly susceptible to infec-
tion with antibiotic-dependent pathogens
such as C. difficile or Salmonella enterica
serovar Typhimurium (S. Typhimurium)
(Stecher et al., 2013). In a recent issue of
Nature, Ng et al. (2013) provide deeper in-
sights into the underlying mechanisms
(Ng et al., 2013). The authors investigate
the interaction of S. Typhimurium and
C. difficile with the microbiota, employing
gnotobiotic mice, monoassociated with
Bacteroides thetaiotaomicron (B. theta)
as a reductionist model system. B. theta
is a common colonizer of the human gut
and produces a variety of outer-mem-
brane polysaccharide-binding proteins
and glycoside hydrolases, which the
bacterium uses to degrade both dietary
and mucin-derived polysaccharides.
To study the response of a pathogen to
its competing microbiota, Ng et al. (2013)
compared the transcriptome of S. Typhi-
murium in B. theta monoassociated and
germfree (GF) mice. Most prominently,
S. Typhimurium genes involved in meta-
bolism of the mucin-derived sugars
sialic acid (nan genes) and fucose (fuc
genes) were found to be upregulated
in a B. theta-dependent manner. Sialicptember 11, 2013 ª2013 Elsevier Inc. 225
Figure 1. Overview of the Mechanisms of Pathogen Infection upon Antibiotic Therapy
(A) Preantibiotic treatment: under homeostatic conditions, polysaccharide-degrading members of the
microbial community break down mucin-derived polysaccharides. Liberated monosaccharides are
rapidly consumed by the microbial food web, leading to overall limitation of free sugars. Additionally,
innate immune defenses (e.g., expression of RegIIIg) are stimulated by microbial TLR ligands.
(B) Postantibiotic treatment I: antibiotics disrupt microbial nutrient networks in the gut and lead to a tran-
sient increase in free monosaccharides (Ng et al., 2013). Further, antibiotic treatment triggers a mild
inflammatory response, which leads to iNOS-dependent generation of NO3
 in the gut (Spees et al.,
2013). In addition, the decreased load of luminal TLR ligands reduces MyD88-dependent production of
the antimicrobial lectin RegIIIg (Brandl et al., 2008).
(C) Postantibiotic treatment II: antibiotic-dependent pathogens exploit freemonosaccharides to expand in
the gut. Further, facultative anaerobic bacteria (e.g., E. coli, S. Typhimurium) can utilize NO3
 as an elec-
tron acceptor for anaerobic respiration (Winter et al., 2013).
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sugars of oligosaccharide side chains of
intestinal mucin. In B. theta-associated
mice, the concentration of free sialic
acid (Neu5Ac) was increased 6-fold as
compared to GFmice or mice monoasso-
ciated with a sialidase-deficient B. theta
mutant strain. B. theta produces a siali-
dase, but not the genes for sialic acid uti-
lization, which explains sialic acid accu-
mulation in the gut. These data suggest
that the enteric pathogen S. Typhimurium
uses microbiota-liberated mucin-derived
sialic acid and fucose for growth. In sup-
port of this notion, an S. Typhimurium
mutant strain deficient in sialic acid and
fucose utilization (DnanADfucI) had a
competitive growth defect against wild-
type S. Typhimurium in the presence of
B. theta.226 Cell Host & Microbe 14, September 11, 2Interestingly, the unrelated opportu-
nistic human pathogen C. difficile also
responded with upregulation of the nan
genes in a B. theta-dependent manner.
Growth of C. difficile depended even
more strongly on the availability of free
sialic acid. In addition, the presence of
B. theta as well as oral feeding of sialic
acid lead to a 10-fold increase in path-
ogen burden compared to GF mice on
normal diet.
As sialic acid turned out to be an
important substrate for antibiotic-depen-
dent pathogens, Ng et al. (2013) next
investigated the role of sialic acid during
pathogen infection of conventional mice
harboring a complex microbiota. In un-
treated mice, concentration of free sialic
acid was very low, suggesting efficient
consumption of this sugar by the micro-013 ª2013 Elsevier Inc.bial food web. However, shortly after
antibiotic treatment, a peak in free sialic
acid was observed, which coincided
with high susceptibility to pathogen
infection. Sialic acid levels declined
3 days after antibiotic treatment due to
consumption by the recovering endoge-
nous microbial community. To verify
that sialic acid catabolism is essential
for antibiotic-induced C. difficile ex-
pansion, the authors constructed a
C. difficile nanT-deficient mutant. Infec-
tion experiments in conventional antibi-
otic-treated mice confirmed that the
mutant, unable to exploit sialic acid for
growth, reaches much lower levels as
compared to wild-type C. difficile in the
gut. These findings provide compelling
evidence that transient high levels of
free sugars following antibiotic challenge
may explain a significant part of
antibiotic-mediated disruption of coloni-
zation resistance (Figure 1).
Besides direct microbiota-mediated
effects, several other studies pointed out
alternative host-derived mechanisms
that also play a role in antibiotic-mediated
susceptibility to pathogens (Figure 1).
Brandl et al. (2008) showed that antibi-
otic-mediated microbiota depletion leads
to a transiently compromised innate im-
mune defense in mice. Treatment with
an antibiotic cocktail induced MyD88-
dependent downregulation of intestinal
expression of RegIIIg, a secreted anti-
bacterial C-type lectin. This impeded
gut luminal killing of vancomycin-resis-
tant Enterococcus faecium (VRE). Oral
application of lipopolysaccharide (LPS)
rescued RegIIIg expression in antibiotic-
treated mice, suggesting that a decrease
of microbiota-derived Toll-like receptor
(TLR) ligands upon antibiotic treatment is
causally involved. More recently, Spees
et al. (2013) demonstrated that high-
dose streptomycin treatment induces a
mild inflammatory response in the cecal
mucosa of mice. Previously, pathogen or
dextran sulfate sodium (DSS)-mediated
intestinal inflammation was shown to
cause an inducible nitric oxide synthase
(iNOS)-dependent increase of gut luminal
concentrations of NO3
, which serves as
alternative electron donor and selectively
fosters overgrowth of facultative anaer-
obic bacteria, such as Enterobac-
teriaceae (e.g., E. coli, S. Typhimurium)
in the gut (Winter et al., 2013). Evi-
dently, the increase in NO3
 levels upon
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already sufficient to foster Enterobacter-
iaceae overgrowth.
In summary, recent work has pro-
vided unprecedented insights into the
complex mechanisms of infections by
antibiotic-dependent pathogens (Ng
et al., 2013; Spees et al., 2013). On the
one hand, antibiotics insult the delicate
crosstalk between the microbiota and
the mucosal immune system, thereby
leading to alteration of immune homeo-
stasis, which ultimately increases sus-
ceptibility to pathogens. On the other
hand, antibiotic-dependent disruption of
microbial ecology generates free nutrient
niches, which can be exploited by patho-
gens for infiltrating this complex and sta-
ble ecosystem to initiate disease. Giventhe increased thread of antibiotic-depen-
dent pathogens in hospital settings, the
work of Ng et al. (2013) provides an impor-
tant basis for the future development
of therapeutic intervention against these
infections.REFERENCES
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Cholera toxin (CT) is the factor responsible for watery diarrhea associated with Vibrio cholerae infection. In
this issue, Guichard et al. (2013) report that CT compromises intestinal epithelium barrier function via cyclic
AMP (cAMP)-induced disruption of Rab11- and exocyst-dependent delivery of endocytic recycling cargo to
cell-cell junctions.Infections by Vibrio cholerae remain a
global public health burden. Cholera toxin
(CT) is the toxic factor responsible for the
induction of a unique, profuse, watery
diarrhea of typically 10 to 20 l a day in
adult patients infected by toxigenic
strains of Vibrio cholerae. CT is closely
homologous to the heat-labile toxin pro-
duced by toxigenic strains of Escherichia
coli, the causative agent of traveler’s
diarrhea. As with other enteropathogens
triggering watery diarrhea, the mecha-
nism by which water flows across and
out of the epithelium is not fully under-
stood. Now, Guichard et al. (2013) reveal
that dysfunction of Rab11 and exocyst
machinery, which is triggered by CT via
forced induction of cyclic AMP (cAMP)
signaling, compromises epithelium bar-rier integrity and contributes to efflux
of water and solutes associated with
V. cholera infection.
CT belongs to the AB5 family of toxins. It
is composed of an enzyme (A subunit,
CtxA) associatedwith a pentameric crown
of B polypeptides for binding to GM1 gan-
gliosides at the surface of host cells. CT
enters into cellular vesicles and un-
dergoes a retrograde traffic to the endo-
plasmic reticulum, where the A subunit
translocates into the cytosol. CtxA is a
mono-ADP-ribosyltransferase that works
in combination with the ADP-ribosylation
factor 6 (ARF6) cellular cofactor. CtxA cat-
alyzes the transfer of an ADP-ribose from
nicotinamide adenine dinucleotide (NAD)
onto a key arginine residue in the a-stimu-
lating subunits of heterotrimeric G pro-teins (Gsa). This leads to the activation of
cellular adenylate cyclases at the plasma
membrane provoking a pathological rise
of cAMP. cAMP is a broad signalingmole-
cule that activates different cellular fac-
tors, such as the cAMP-dependent pro-
tein kinase A (PKA), thereby inducing the
phosphorylation of several ion channels.
Notably, this activates the conductance
of the cystic fibrosis transmembrane
conductance regulator (CFTR), a chloride
ion channel (Gabriel et al., 1994). CFTR
drives the efflux of Cl ions and the result-
ing compensatory, andpartly paracellular,
secretion of Na+ (Gabriel et al., 1994). The
net secretion of sodium chloride (NaCl)
generates an osmotic gradient that is
compensated by water efflux. Both
basolaterally located K+ channels and anptember 11, 2013 ª2013 Elsevier Inc. 227
